Hims & Hers Health, Inc.
corporate_fare Company Profile
Hims & Hers Health, Inc. (NYSE:HIMS) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 44 items for HIMS at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Hims' Partner to Reintroduce Controversial GLP-1 Pill After Regulatory Halt
- Hims & Hers Reports Strong 2025 Growth Amid Escalating Regulatory Scrutiny and Patent Lawsuit Over GLP-1 Products
- Hims & Hers Reports Strong FY25 Revenue Growth, Mixed Q4 Profitability, and Issues FY26 Guidance
- Hims & Hers to Acquire Eucalyptus for Up to $1.15B, Accelerating Global Digital Health Expansion
Financial Snapshot
Fiscal year ended December 31, 2025
Revenue
$2.35B
Net Income
$128.37M
Diluted EPS
$0.51
Op. Cash Flow
$300.01M
Free Cash Flow
$57.41M
Gross Profit
$1.73B
Operating Income
$105.61M
Cash & Equivalents
$228.62M
Total Debt
$972.58M
Debt / Equity
1.80×
Net Margin
5.5%
Shares Outstanding
224.96M sh
Source: 10-K · filed 2026-02-23 · accession 0001773751-26-000022
show_chartPrice Chart
Loading chart...
feed HIMS - Filings & News (Page 3)
HIMS
Mar 03, 2026, 10:33 AM EST
Price at Filing:
$15.53
Real-time Price:
$15.13
Change:
-$0.400 (-3%)
Market Cap:
$3.422B
HIMS
Feb 23, 2026, 5:20 PM EST
Price at Filing:
$15.20
Real-time Price:
$15.13
Change:
-$0.070 (-0.46%)
Market Cap:
$3.422B
HIMS
Feb 23, 2026, 4:07 PM EST
Price at Filing:
$14.90
Real-time Price:
$15.13
Change:
+$0.2269 (+2%)
Market Cap:
$3.422B
HIMS
Feb 19, 2026, 6:19 AM EST
Price at Filing:
$15.99
Real-time Price:
$15.13
Change:
-$0.860 (-5%)
Market Cap:
$3.422B